Concepedia

Rita De Micheli

RD

Statistics

Publications

4

Citations

163

H-Index

4

Active since

1996

Affiliations

University of Lausanne(Current)

University Hospital of Lausanne

Rita De Micheli is an author at University of Lausanne specializing in oncology, medicine, and pharmacology.

Publications per year

1996–2024

4

Publications

4

Natalizumab may control immune checkpoint inhibitor–induced limbic encephalitis

Andreas F. Hottinger, Rita De Micheli, Vanessa Guido et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 117 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB).

Andreas F. Hottinger, Marc Sanson, Elizabeth Moyal et al. · Journal of Clinical Oncology · 2016 · 20 citations

Medicine, Oncology, Pharmacology +15

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)

PierFranco Conte, Editta Baldini, G. Gardin et al. · Annals of Oncology · 1996 · 15 citations · Full text

Medicine, Endocrinology, Oncology +16

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

Victor Joo, Karim Abdelhamid, Alessandra Noto et al. · Nature Communications · 2024 · 11 citations · Full text

Medicine, Immunology, Pharmacology +17

1–4 of 4